UK markets open in 2 hours 23 minutes
NIKKEI 225
38,721.14 +230.97 (+0.60%) HANG SENG
18,533.22 +108.26 (+0.59%) CRUDE OIL
74.50 +0.43 (+0.58%) GOLD FUTURES
2,387.50 +12.00 (+0.51%) DOW
38,807.33 +96.04 (+0.25%) Bitcoin GBP
55,466.61 -75.71 (-0.14%)
Zhende Medical Co., Ltd. (603301.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
As of 11:29AM CST. Market open.
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 5.66B |
| Enterprise value | 5.22B |
| Trailing P/E | 45.17 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.50 |
| Price/book (mrq) | 1.03 |
| Enterprise value/revenue | 1.38 |
| Enterprise value/EBITDA | 32.14 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.39 |
| 52-week change 3 | -32.32% |
| S&P500 52-week change 3 | 24.69% |
| 52-week high 3 | 32.13 |
| 52-week low 3 | 15.68 |
| 50-day moving average 3 | 21.11 |
| 200-day moving average 3 | 23.62 |
Share statistics
| Avg vol (3-month) 3 | 1.58M |
| Avg vol (10-day) 3 | 921.31k |
| Shares outstanding 5 | 266.45M |
| Implied shares outstanding 6 | 266.45M |
| Float 8 | 103.89M |
| % held by insiders 1 | 61.80% |
| % held by institutions 1 | 8.83% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.5 |
| Forward annual dividend yield 4 | 7.07% |
| Trailing annual dividend rate 3 | 1.25 |
| Trailing annual dividend yield 3 | 5.89% |
| 5-year average dividend yield 4 | 2.79 |
| Payout ratio 4 | 319.15% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 31 Oct 2023 |
| Last split factor 2 | 1.4:1 |
| Last split date 3 | 08 Jun 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 3.31% |
| Operating margin (ttm) | 9.45% |
Management effectiveness
| Return on assets (ttm) | 1.24% |
| Return on equity (ttm) | 2.42% |
Income statement
| Revenue (ttm) | 3.79B |
| Revenue per share (ttm) | 14.19 |
| Quarterly revenue growth (yoy) | -25.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 405.11M |
| Net income avi to common (ttm) | 125.34M |
| Diluted EPS (ttm) | 0.47 |
| Quarterly earnings growth (yoy) | -49.90% |
Balance sheet
| Total cash (mrq) | 1.74B |
| Total cash per share (mrq) | 6.64 |
| Total debt (mrq) | 1.3B |
| Total debt/equity (mrq) | 22.79% |
| Current ratio (mrq) | 2.46 |
| Book value per share (mrq) | 20.86 |
Cash flow statement
| Operating cash flow (ttm) | 683.78M |
| Levered free cash flow (ttm) | -101.1M |
© 2024 Yahoo. All rights reserved.